Spyre Therapeutics Inc (SYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 85,721 | 89,423 | 188,893 | 34,863 | 15,142 |
| Marketable Securities | 670,812 | 513,665 | 150,384 | 20,848 | 77,986 |
| Receivables | N/A | N/A | N/A | 375 | 815 |
| TOTAL | $777,781 | $608,474 | $341,528 | $62,258 | $98,891 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | 3,220 | 4,549 |
| Other Non-Current Assets | 0 | 10 | 331 | 5,666 | 6,486 |
| TOTAL | $N/A | $10 | $331 | $8,886 | $11,035 |
| Total Assets | $777,781 | $608,484 | $341,859 | $71,144 | $109,926 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,918 | 1,269 | 17,480 | 677 | 3,319 |
| Accrued Expenses | 26,947 | 27,711 | 13,108 | 12,837 | 14,030 |
| Other current liabilities | 22,820 | 25,080 | 1,390 | 0 | N/A |
| TOTAL | $58,685 | $54,060 | $31,978 | $14,656 | $20,144 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | 517 | 2,359 |
| Other Non-Current Liabilities | 3,860 | 36,620 | 125,865 | 4,004 | 4,624 |
| TOTAL | $3,860 | $36,620 | $125,865 | $6,183 | $5,841 |
| Total Liabilities | $62,545 | $90,680 | $157,843 | $20,839 | $25,985 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 78,540 | 60,276 | 36,151 | 2,616 | 1,974 |
| Common Shares | 15 | 13 | 10 | 6 | 5 |
| Retained earnings | -1,127,635 | -972,432 | -764,414 | -425,624 | -341,809 |
| Other shareholders' equity | 156,689 | 156,000 | 185,229 | -48 | -20 |
| TOTAL | $715,236 | $517,804 | $184,016 | $50,305 | $83,941 |
| Total Liabilities And Equity | $777,781 | $608,484 | $341,859 | $71,144 | $109,926 |